Synchron Research Pvt Ltd has entered into a strategic partnership with the US-based Parexel International to monitor clinical trial sites in India, Malaysia, Nepal, Sri Lanka and Pakistan.

The CRO has teamed-up with Symogen a UK-based pharmacovigilance company for effective implementation of Pharmacovigilance activities and set up an independent unit for commencing the services in India.

The Rs 6-crore Ahmedabad-based Synchron commenced its operations in Bangalore two years ago. The facility in Bangalore will conduct phase II to phase IV studies and investment of around Rs 1crore has been made to install the software and hardware including MedDRA and WHO dictionary to speed-up its clinical research and data management studies, Dr. Shivprakash, managing director, Synchron Research Services Pvt Ltd told Pharmabiz.com

As a first step on its association with Symogen, Synchron had organised a one-day seminar on Pharmacovigilance in Bangalore.